The perinucleolar compartment is directly associated with DNA

Area of Science:

• Nuclear biology
• Cancer cell biology
• Molecular oncology

Background:

• The perinucleolar compartment (PNC) is a nuclear subdomain exclusive to tumor cells.
• PNC prevalence correlates with tumor malignancy, making it a potential biomarker.
• Understanding PNC structure and function is crucial for cancer research.

Purpose of the Study:

• To investigate the structure and function of the PNC using anti-cancer drugs and other stimuli.
• To identify molecular mechanisms underlying PNC disassembly.
• To explore the role of DNA integrity in PNC maintenance.

Main Methods:

• Screening of clinically used anti-cancer drugs for their effect on PNCs.
• Utilizing transcription inhibitors and DNA-damaging agents (e.g., UV radiation).
• Inhibiting cellular DNA damage response pathways.
• Analyzing DNA damage types causing PNC disassembly.
• Cell biology experiments on endoreplication and PNC splitting.

Main Results:

• Two classes of anti-cancer drugs were identified that disassemble PNCs via distinct molecular actions.
• Transcription inhibitors reduce PNC prevalence by decreasing RNA polymerase III transcription.
• DNA-damaging agents and UV radiation disassemble PNCs, dependent on DNA integrity, not the response.
• PNC disassembly is linked to interstrand DNA base pairing, suggesting direct DNA interaction.
• PNCs increase with endoreplication and split during S phase, mirroring replicating DNA loci behavior.

Conclusions:

• PNC disassembly is a validated screening marker for identifying chemical probes targeting cancer cells.
• PNC maintenance is dependent on DNA integrity, with interstrand DNA base pairing being critical.
• The PNC is nucleated on a DNA locus, suggesting a potential role in gene expression regulation.